GCIA
XBI icon

Gabelli & Co Investment Advisers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,530
Closed -$343K – 456
2021
Q1 		$343K Buy
+2,530
New +$379K 0.04% 264

Other funds holding XBI

Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Gabelli & Co Investment Advisers's XBI Position: Q2 2021 in Review

Gabelli & Co Investment Advisers sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2021, closing a stake of 2,530 shares — an estimated $343K sold.

Gabelli & Co Investment Advisers first reported a position in XBI in Q1 2021 and held it in 1 quarter. The position peaked at $343K in Q1 2021. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.

  • Gabelli & Co Investment Advisers reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2021 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 2,530 State Street SPDR S&P Biotech ETF shares in Q2 2021, an estimated $343K.
  • Gabelli & Co Investment Advisers first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's State Street SPDR S&P Biotech ETF position peaked at $343K in Q1 2021.
  • 663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.